Customize your JAMA Network experience by selecting one or more topics from the list below.
In the Original Investigation titled “Response Rate Following Albumin-Bound Paclitaxel Plus Gemcitabine Plus Cisplatin Treatment Among Patients With Advanced Pancreatic Cancer: A Phase 1b/2 Pilot Clinical Trial,”1 published in JAMA Oncology online first on October 3, 2019, eTable 3 was missing from Supplement 2. It has been added to Supplement 2 and cited in the Results. This article was corrected online.
Missing eTable. JAMA Oncol. 2019;5(11):1643. doi:10.1001/jamaoncol.2019.5486
Coronavirus Resource Center
Create a personal account or sign in to: